Scholarlink

Background <p>Nonalcoholic fatty liver disease (NAFLD), also termed metabolic dysfunction‑associated fatty liver disease is a problem across the world. The most important factor of the increase in NAFLD prevalence is the insulin resistance. This study is the first clinical trial with the aim of determining the effect of <i>Pistacia atlantica</i> Sub. <i>Kurdica</i> gum on glycemic indices especially insulin resistance in patients with nonalcoholic fatty liver disease.</p> Methods <p>In this double-blind randomized clinical trial 50 patients with nonalcoholic fatty liver disease were randomized into two groups: those given syrup containing <i>Pistacia atlantica</i> sub. <i>Kurdica</i> gum (Group A), those on placebo (Group B). Over a two-month period, Group A given syrup containing 500&#xa0;mg of <i>P. atlantica sub. Kurdica</i> gum per each tablespoon and Group B given syrup without <i>P. atlantica sub. Kurdica</i> gum. Anthropometric measures, biochemical indices and physical activity were evaluated at the beginning and end of the intervention.</p> Results <p>We observed a significant decrease in fatty liver grade in group A (<i>P</i> = 0.03). The mean of fasting serum insulin and the insulin-resistance index (HOMA-IR) decreased significantly (<i>P</i> = 0.002, <i>P</i> &lt; 0.001) and quantitative insulin sensitivity check index (QUICKI) increased from baseline in group A (<i>P</i> = 0.001). Fasting blood sugar (FBS) decreased significantly from baseline in group A (<i>P</i> = 0.019), but the mean changes between group not significant (<i>P</i> = 0.061). Weight had significant decrease in group A (<i>P</i> &lt; 0.001).</p> Conclusions <p><i>Pistacia atlantica</i> sub. <i>Kurdica</i> gum can decrease insulin resistance, increase insulin sensitivity and subsequently improvement NAFLD in patient with nonalcoholic fatty liver disease. It is suggested that clinical trials be conducted in the long duration of the intervention, as well as a larger sample size.</p> Trial registration <p>Registration number of Clinical trial: IRCT20231219060466N1 (<a href="https://irct.behdasht.gov.ir/">https://irct.behdasht.gov.ir/</a>).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pistacia atlantica sub. Kurdica can improve insulin resistance in patients with non-alcoholic fatty liver disease: a randomized clinical trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月3日

查看全文
  • Roghayeh Mostafaei,
  • Seyed Mostafa Nachvak,
  • Amir Saber,
  • Behzad Mahaki,
  • Nazanin Jalilian,
  • Leila Behbood,
  • Mohammad Gharib Salehi,
  • Behzad Heidarpour,
  • Roghaye Farhadi Hassankiadeh

摘要

Background

Nonalcoholic fatty liver disease (NAFLD), also termed metabolic dysfunction‑associated fatty liver disease is a problem across the world. The most important factor of the increase in NAFLD prevalence is the insulin resistance. This study is the first clinical trial with the aim of determining the effect of Pistacia atlantica Sub. Kurdica gum on glycemic indices especially insulin resistance in patients with nonalcoholic fatty liver disease.

Methods

In this double-blind randomized clinical trial 50 patients with nonalcoholic fatty liver disease were randomized into two groups: those given syrup containing Pistacia atlantica sub. Kurdica gum (Group A), those on placebo (Group B). Over a two-month period, Group A given syrup containing 500 mg of P. atlantica sub. Kurdica gum per each tablespoon and Group B given syrup without P. atlantica sub. Kurdica gum. Anthropometric measures, biochemical indices and physical activity were evaluated at the beginning and end of the intervention.

Results

We observed a significant decrease in fatty liver grade in group A (P = 0.03). The mean of fasting serum insulin and the insulin-resistance index (HOMA-IR) decreased significantly (P = 0.002, P < 0.001) and quantitative insulin sensitivity check index (QUICKI) increased from baseline in group A (P = 0.001). Fasting blood sugar (FBS) decreased significantly from baseline in group A (P = 0.019), but the mean changes between group not significant (P = 0.061). Weight had significant decrease in group A (P < 0.001).

Conclusions

Pistacia atlantica sub. Kurdica gum can decrease insulin resistance, increase insulin sensitivity and subsequently improvement NAFLD in patient with nonalcoholic fatty liver disease. It is suggested that clinical trials be conducted in the long duration of the intervention, as well as a larger sample size.

Trial registration

Registration number of Clinical trial: IRCT20231219060466N1 (https://irct.behdasht.gov.ir/).